April 26, 2018 / 11:12 AM / 7 months ago

BRIEF-Foundation Medicine's New Liquid Biopsy Assay Granted Breakthrough Device Designation By U.S. FDA

April 26 (Reuters) - Foundation Medicine Inc:

* FOUNDATION MEDICINE’S NEW LIQUID BIOPSY ASSAY GRANTED BREAKTHROUGH DEVICE DESIGNATION BY U.S. FOOD AND DRUG ADMINISTRATION

* FOUNDATION MEDICINE- NEW ASSAY WILL INCLUDE OVER 70 GENES, GENOMIC BIOMARKERS FOR MICROSATELLITE INSTABILITY & BLOOD TUMOR MUTATIONAL BURDEN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below